Acknowledgement to Referees Acknowledgement to Referees Open access 23 November 2022 Pages: 539 - 542
A Review of Research Studies Using Data from the Administrative Claims Databases in Japan Jun FujinagaToshio Fukuoka Review Article Open access 15 September 2022 Pages: 543 - 550
Drug-Induced QT Prolongation and Torsade de Pointes in Spontaneous Adverse Event Reporting: A Retrospective Analysis Using the Japanese Adverse Drug Event Report Database (2004–2021) Mayu UchikawaMasayuki HashiguchiTsuyoshi Shiga Original Research Article Open access 22 August 2022 Pages: 551 - 559
Prophylactic Antimicrobial Prescribing in Australian Residential Aged-Care Facilities: Improvement is Required Noleen BennettMichael J. MalloyLeon J. Worth Original Research Article Open access 13 August 2022 Pages: 561 - 567
Factors Associated with Discontinuation of Statin Therapy in Patients with Lymphoma Aged 80 Years and Older: A Retrospective Single-Institute Study Satoshi YamasakiTomotake TokunouTakahiko Horiuchi Original Research Article Open access 18 June 2022 Pages: 569 - 575
Treatment Pathways and Health Outcomes of German Patients with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Health Claims Data Analysis Christof ScheidRobert KudernatschJörg Mahlich Original Research Article Open access 02 July 2022 Pages: 577 - 588
Effectiveness and Safety of Filgrastim (Neupogen™) versus Filgrastim-aafi (Nivestim™) in Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia: An Observational Cohort Study Abeer A. Al-RabayahOla Al MashniSuzan S. Hammoudeh Original Research Article Open access 07 September 2022 Pages: 589 - 595
Increased Risk of Stroke Due to Non-adherence and Non-persistence with Direct Oral Anticoagulants (DOACs): Real-World Analyses Using a Nested Case–Control Study from The Netherlands, Italy and Germany Emily HolthuisElisabeth SmitsRon Herings Original Research Article Open access 05 July 2022 Pages: 597 - 607
Retrospective Cohort Evaluating the Comparative Effectiveness of Ceftaroline and Daptomycin as First-Line Therapies for Inpatient Treatment of Diabetic Foot Infection in the United States Veterans Health Care System Alyssa C. EavesChengwen TengChristopher R. Frei Original Research Article Open access 15 July 2022 Pages: 609 - 615
Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry Philip J. MeaseAlexis OgdieJoseph F. Merola Original Research Article Open access 15 October 2022 Pages: 617 - 628
Trends in the Use of Sedative-Hypnotics, Opioids, and Neuromuscular Blockers in Hospitalized Patients During the COVID-19 Pandemic: Observational Retrospective Study Manuel E. Machado-DuqueAndrés Gaviria-MendozaJorge Enrique Machado-Alba Original Research Article Open access 03 November 2022 Pages: 629 - 638
Rituximab and Pyoderma Gangrenosum: An Investigation of Disproportionality Using a Systems Biology-Informed Approach in the FAERS Database Jodie Belinda HillenTy StanfordNicole Pratt Original Research Article Open access 06 August 2022 Pages: 639 - 647
Effect of Tolvaptan in Patients with Chronic Kidney Disease Stage G5, and Impact of Concomitant Use of Thiazide Diuretics: A Retrospective Cohort Study Kiyotaka UchiyamaDaiki KojimaHiroshi Itoh Original Research Article Open access 13 August 2022 Pages: 649 - 657
Osteonecrosis of the Jaw Caused by Denosumab in Treatment-Naïve and Pre-Treatment with Zoledronic Acid Groups: A Time-to-Onset Study Using the Japanese Adverse Drug Event Report (JADER) Database Shiori HasegawaHiroaki IkesueMitsuhiro Nakamura Original Research Article Open access 06 August 2022 Pages: 659 - 665
Adverse Drug Events Related to Common Asthma Medications in US Hospitalized Children, 2000–2016 Luyu XieAndrew GelfandSarah E. Messiah Original Research Article Open access 08 June 2022 Pages: 667 - 679
Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2− Metastatic Breast Cancer Treated with Abemaciclib Emily Nash SmythJulie BeyrerSarah Rybowski Original Research Article Open access 12 September 2022 Pages: 681 - 693